Alnylam Pharmaceuticals, Inc. (LON:0HD2)

Alnylam Pharmaceuticals Statistics

Total Valuation

LON:0HD2 has a market cap or net worth of GBP 33.05 billion. The enterprise value is 33.09 billion.

Market Cap	33.05B
Enterprise Value	33.09B

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	132.62M
Shares Outstanding	n/a
Shares Change (YoY)	+5.51%
Shares Change (QoQ)	-0.78%
Owned by Insiders (%)	0.34%
Owned by Institutions (%)	98.85%
Float	132.12M

Valuation Ratios

The trailing PE ratio is 141.76 and the forward PE ratio is 33.60.

PE Ratio	141.76
Forward PE	33.60
PS Ratio	11.98
PB Ratio	56.36
P/TBV Ratio	56.36
P/FCF Ratio	95.57
P/OCF Ratio	84.87
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 70.69, with an EV/FCF ratio of 95.70.

EV / Earnings	141.95
EV / Sales	12.02
EV / EBITDA	70.69
EV / EBIT	89.01
EV / FCF	95.70

Financial Position

The company has a current ratio of 2.76, with a Debt / Equity ratio of 3.76.

Current Ratio	2.76
Quick Ratio	2.51
Debt / Equity	3.76
Debt / EBITDA	4.70
Debt / FCF	6.38
Interest Coverage	1.99

Financial Efficiency

Return on equity (ROE) is 73.28% and return on invested capital (ROIC) is 86.03%.

Return on Equity (ROE)	73.28%
Return on Assets (ROA)	6.81%
Return on Invested Capital (ROIC)	86.03%
Return on Capital Employed (ROCE)	14.33%
Weighted Average Cost of Capital (WACC)	6.16%
Revenue Per Employee	1.10M
Profits Per Employee	93,246
Employee Count	2,500
Asset Turnover	0.81
Inventory Turnover	8.46

Taxes

In the past 12 months, LON:0HD2 has paid 6.99 million in taxes.

Income Tax	6.99M
Effective Tax Rate	2.91%

Stock Price Statistics

The stock price has increased by +35.76% in the last 52 weeks. The beta is 0.32, so LON:0HD2's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	+35.76%
50-Day Moving Average	370.12
200-Day Moving Average	387.85
Relative Strength Index (RSI)	46.39
Average Volume (20 Days)	241

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.36

Income Statement

In the last 12 months, LON:0HD2 had revenue of GBP 2.76 billion and earned 233.11 million in profits. Earnings per share was 1.73.

Revenue	2.76B
Gross Profit	2.25B
Operating Income	372.67M
Pretax Income	240.10M
Net Income	233.11M
EBITDA	414.03M
EBIT	372.67M
Earnings Per Share (EPS)	1.73

Balance Sheet

The company has 2.16 billion in cash and 2.21 billion in debt, with a net cash position of -44.81 million.

Cash & Cash Equivalents	2.16B
Total Debt	2.21B
Net Cash	-44.81M
Net Cash Per Share	n/a
Equity (Book Value)	586.36M
Book Value Per Share	4.43
Working Capital	1.92B

Cash Flow

In the last 12 months, operating cash flow was 389.39 million and capital expenditures -43.61 million, giving a free cash flow of 345.78 million.

Operating Cash Flow	389.39M
Capital Expenditures	-43.61M
Free Cash Flow	345.78M
FCF Per Share	n/a

Margins

Gross margin is 81.64%, with operating and profit margins of 13.51% and 8.45%.

Gross Margin	81.64%
Operating Margin	13.51%
Pretax Margin	8.70%
Profit Margin	8.45%
EBITDA Margin	15.00%
EBIT Margin	13.51%
FCF Margin	12.53%

Dividends & Yields

LON:0HD2 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.51%
Shareholder Yield	-5.51%
Earnings Yield	0.71%
FCF Yield	1.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0HD2 has an Altman Z-Score of 6.35 and a Piotroski F-Score of 5.

Altman Z-Score	6.35
Piotroski F-Score	5